Mary McNamara-Cullinane
Consejero General en CLEARPOINT NEURO, INC. .
Cargos activos de Mary McNamara-Cullinane
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CLEARPOINT NEURO, INC. | Consejero General | 08/08/2022 | - |
Historial de carrera de Mary McNamara-Cullinane
Antiguos cargos conocidos de Mary McNamara-Cullinane.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Molecular Biometrics, Inc.
 Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | Consejero General | - | - |
| ECHO THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 19/12/2013 | - |
| Consejero General | 19/12/2013 | - | |
| Corporate Officer/Principal | - | 19/12/2013 |
Formación de Mary McNamara-Cullinane.
| Massachusetts College of Liberal Arts | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| General Counsel | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CLEARPOINT NEURO, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Echo Therapeutics, Inc.
 Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | Commercial Services |
